tomeko

Muscular dystrophy, limb-girdle, autosomal recessive 23

Just diagnosed with Muscular dystrophy, limb-girdle, autosomal recessive 23?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Muscular dystrophy, limb-girdle, autosomal recessive 23, look for clinical trials, and connect with others living with it — all in one place.

Open the full Muscular dystrophy, limb-girdle, autosomal recessive 23 hub →

Overview

Muscular dystrophy, limb-girdle, autosomal recessive 23 is a rare condition. Also known as LGMD type R23, Laminin subunit alpha 2-related LGMD R23, Laminin subunit alpha 2-related late-onset muscular dystrophy. Tomeko brings together the specialists, research, clinical trials, treatments and community for Muscular dystrophy, limb-girdle, autosomal recessive 23 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:565837 · OMIM 618138 · ICD-10 G71.0 · GARD 0022270

Find care for Muscular dystrophy, limb-girdle, autosomal recessive 23

Authoritative references for Muscular dystrophy, limb-girdle, autosomal recessive 23

Common questions

I was just diagnosed with Muscular dystrophy, limb-girdle, autosomal recessive 23 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Muscular dystrophy, limb-girdle, autosomal recessive 23, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Muscular dystrophy, limb-girdle, autosomal recessive 23?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Muscular dystrophy, limb-girdle, autosomal recessive 23, filtered to your area.

Are there clinical trials for Muscular dystrophy, limb-girdle, autosomal recessive 23?

Tomeko shows live, recruiting studies for Muscular dystrophy, limb-girdle, autosomal recessive 23 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com